CRDF
Price
$1.58
Change
-$0.09 (-5.36%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
113.17M
22 days until earnings call
Intraday BUY SELL Signals
MRKR
Price
$1.81
Change
-$0.04 (-2.16%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
30.85M
Intraday BUY SELL Signals
Interact to see
Advertisement

CRDF vs MRKR

Header iconCRDF vs MRKR Comparison
Open Charts CRDF vs MRKRBanner chart's image
Cardiff Oncology
Price$1.58
Change-$0.09 (-5.36%)
Volume$18.84K
Capitalization113.17M
Marker Therapeutics
Price$1.81
Change-$0.04 (-2.16%)
Volume$810
Capitalization30.85M
CRDF vs MRKR Comparison Chart in %
CRDF
Daily Signal:
Gain/Loss:
MRKR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRDF vs. MRKR commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDF is a Hold and MRKR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CRDF: $1.68 vs. MRKR: $1.85)
Brand notoriety: CRDF and MRKR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRDF: 76% vs. MRKR: 94%
Market capitalization -- CRDF: $113.17M vs. MRKR: $30.85M
CRDF [@Biotechnology] is valued at $113.17M. MRKR’s [@Biotechnology] market capitalization is $30.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDF’s FA Score shows that 0 FA rating(s) are green whileMRKR’s FA Score has 1 green FA rating(s).

  • CRDF’s FA Score: 0 green, 5 red.
  • MRKR’s FA Score: 1 green, 4 red.
According to our system of comparison, MRKR is a better buy in the long-term than CRDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDF’s TA Score shows that 4 TA indicator(s) are bullish while MRKR’s TA Score has 4 bullish TA indicator(s).

  • CRDF’s TA Score: 4 bullish, 6 bearish.
  • MRKR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MRKR is a better buy in the short-term than CRDF.

Price Growth

CRDF (@Biotechnology) experienced а -16.00% price change this week, while MRKR (@Biotechnology) price change was +2.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

CRDF is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRDF($113M) has a higher market cap than MRKR($30.8M). MRKR YTD gains are higher at: 24.161 vs. CRDF (-40.214). MRKR has higher annual earnings (EBITDA): -7.82M vs. CRDF (-53.33M). CRDF has more cash in the bank: 60.6M vs. MRKR (17.6M). MRKR has less debt than CRDF: MRKR (0) vs CRDF (1.01M). MRKR has higher revenues than CRDF: MRKR (6.59M) vs CRDF (501K).
CRDFMRKRCRDF / MRKR
Capitalization113M30.8M367%
EBITDA-53.33M-7.82M682%
Gain YTD-40.21424.161-166%
P/E RatioN/AN/A-
Revenue501K6.59M8%
Total Cash60.6M17.6M344%
Total Debt1.01M0-
FUNDAMENTALS RATINGS
CRDF vs MRKR: Fundamental Ratings
CRDF
MRKR
OUTLOOK RATING
1..100
5170
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
9239
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRKR's Valuation (20) in the Other Consumer Services industry is in the same range as CRDF (50) in the null industry. This means that MRKR’s stock grew similarly to CRDF’s over the last 12 months.

MRKR's Profit vs Risk Rating (100) in the Other Consumer Services industry is in the same range as CRDF (100) in the null industry. This means that MRKR’s stock grew similarly to CRDF’s over the last 12 months.

MRKR's SMR Rating (99) in the Other Consumer Services industry is in the same range as CRDF (99) in the null industry. This means that MRKR’s stock grew similarly to CRDF’s over the last 12 months.

MRKR's Price Growth Rating (39) in the Other Consumer Services industry is somewhat better than the same rating for CRDF (92) in the null industry. This means that MRKR’s stock grew somewhat faster than CRDF’s over the last 12 months.

MRKR's P/E Growth Rating (100) in the Other Consumer Services industry is in the same range as CRDF (100) in the null industry. This means that MRKR’s stock grew similarly to CRDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRDFMRKR
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 14 days ago
86%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CRDF
Daily Signal:
Gain/Loss:
MRKR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLG13.970.47
+3.48%
Flagstar Bank National Association
ORGN0.19N/A
+2.54%
Origin Materials
ENB49.331.05
+2.17%
Enbridge
INV3.280.01
+0.31%
Innventure Inc
PSNYW2.75-0.04
-1.43%
Polestar Automotive Hldg

CRDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDF has been loosely correlated with ORMP. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDF jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDF
1D Price
Change %
CRDF100%
-1.75%
ORMP - CRDF
39%
Loosely correlated
+0.29%
CADL - CRDF
37%
Loosely correlated
+0.85%
MRNA - CRDF
35%
Loosely correlated
-0.82%
NRIX - CRDF
35%
Loosely correlated
-1.76%
AVBP - CRDF
34%
Loosely correlated
-0.15%
More

MRKR and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRKR has been loosely correlated with CRDF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MRKR jumps, then CRDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRKR
1D Price
Change %
MRKR100%
+8.19%
CRDF - MRKR
35%
Loosely correlated
-1.75%
NAGE - MRKR
34%
Loosely correlated
-6.81%
CLDX - MRKR
33%
Poorly correlated
+2.07%
ZURA - MRKR
33%
Poorly correlated
+9.53%
XNCR - MRKR
32%
Poorly correlated
-0.99%
More